MedTrace Logo

Potential Influence of Esomeprazole on the Pharmacokinetics of Pritelivir

NCT05513625 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2024-02-22

Study results available
· View outcomes & findings →

Summary

To investigate the effect of esomeprazole (ESO) on the pharmacokinetics of pritelivir (PTV), and to investigate the safety and tolerability of PTV.

Conditions

  • HSV Infection

Interventions

DRUG

Pritelivir

oral administration

DRUG

ESO and pritelivir

oral administration

Sponsors & Collaborators

  • AiCuris Anti-infective Cures AG

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-13
Primary Completion
2020-10-13
Completion
2020-10-13
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05513625 on ClinicalTrials.gov